Navigation Links
Vanda Presents Phase III Iloperidone Efficacy Data
Date:12/12/2007

to 20-24 mg/day; similar reductions in BPRS scores were observed at six weeks for iloperidone in doses of 20-24 mg/day, as compared to the active comparators risperidone and haloperidol. The analysis further demonstrated that iloperidone had a favorable safety profile, most notably with regard to extrapyramidal symptoms (EPS) and akathisia rates, weight and metabolic parameters, and prolactin levels.

Unmet Needs in Schizophrenia

Schizophrenia is a chronic, severe and disabling brain disorder that affects approximately one percent of Americans. Although there are many drugs approved to treat schizophrenia, including the commonly prescribed "atypical antipsychotics," a high degree of dissatisfaction remains among physicians and patients. The recent CATIE (Clinical Antipsychotic Trials of Intervention Effectiveness) study, conducted by the National Institute of Mental Health (NIMH) and reported in The New England Journal of Medicine, evaluated several antipsychotic medications and revealed that 74 percent of patients taking antipsychotics discontinued treatment within 18 months, primarily because of insufficient efficacy and tolerability issues.

About Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc. is a biopharmaceutical company with a focus on the development and commercialization of clinical-stage product candidates for central nervous system disorders. The company has three product candidates in clinical development. In addition to iloperidone, Vanda is developing VEC- 162, a compound for the treatment of sleep and mood disorders which is currently in Phase III development for sleep disorders. Vanda's third product candidate in clinical development, VSF-173, is currently in Phase II development for the treatment of excessive sleepiness. For more on Vanda Pharmaceuticals Inc., please visit http://www.vandapharma.com.

Note Regarding Forward-Looking Statements

This re
'/>"/>

SOURCE Vanda Pharmaceuticals Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Vanda Pharmaceuticals Submits Iloperidone New Drug Application
2. Vanda Pharmaceuticals Reports Third Quarter 2007 Results
3. Vanda Pharmaceuticals Receives FDA Acceptance of Iloperidone New Drug Application
4. Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
5. EntreMed Presents Data for Phase 2 Study of MKC-1 in Metastatic Breast Cancer
6. Pharmasset Presents R7128 Phase 1 Single Ascending Dose Study in Healthy Volunteers
7. Anadys Pharmaceuticals Presents Preclinical Results on ANA598, a Non-Nucleoside Inhibitor of the NS5B Polymerase, at the 14th International Symposium on Hepatitis C Virus and Related Viruses
8. CEL-SCI Presents Data for CEL-1000 as a Vaccine Adjuvant with Recombinant Hepatitis B Virus Protein
9. Ardea Biosciences, Inc. Presents Results of Phase 1 Studies of RDEA806, a Novel NNRTI for HIV, at 47th ICAAC
10. Targanta Presents First Data Demonstrating In Vitro Activity and In Vivo Efficacy of Prodrugs in Osteomyelitis Models
11. Wyeth Presents Phase 3 Fracture Data for Bazedoxifene, an Investigational Therapy for Osteoporosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2015)... , July 27, 2015  QT Vascular Ltd., ... a global company engaged in the design, assembly and ... treatment of vascular disease, has entered into an agreement ... to US$13.14 million convertible bond investment. This funding will ... its growth to the next milestone. ...
(Date:7/27/2015)... July 27, 2015 As per the ... - Global Industry Analysis, Size, Share, Growth, Trends and Forecast ... 7.96 billion in 2014, growing at a CAGR of 13.2% ... in 2021. The global bionics market is growing ... which is leading to paralysis or amputation of body parts. ...
(Date:7/27/2015)... SALT LAKE CITY , July 27, 2015 Dynatronics ... Mark approval for its Solaris therapeutic modality products. This approval allows ... and many other countries around the world. "Receiving ... our international sales efforts," stated Kelvyn H. Cullimore Jr. , ... have expanded our distribution network into China , ...
Breaking Medicine Technology:QT Vascular Obtains Funding To Boost Growth Through Issuance of up to US$13.14 Million Convertible Bonds 2QT Vascular Obtains Funding To Boost Growth Through Issuance of up to US$13.14 Million Convertible Bonds 3Global Bionics Market is Expected to Reach USD 20.49 Billion in 2021, Growing at CAGR of 13.2% From 2015 to 2021: Transparency Market Research 2Global Bionics Market is Expected to Reach USD 20.49 Billion in 2021, Growing at CAGR of 13.2% From 2015 to 2021: Transparency Market Research 3Global Bionics Market is Expected to Reach USD 20.49 Billion in 2021, Growing at CAGR of 13.2% From 2015 to 2021: Transparency Market Research 4Dynatronics Awarded CE Mark Approval for Its Solaris Products 2
... Medical Imaging of Fredericksburg is one of six ...  Best of 2011 Radiology Facilities issue, a national ... In an article titled "Small Town Sensibility, ... of Fredericksburg, a partnership between Mary Washington Healthcare ...
... Hologic, Inc. (Hologic or the Company) (Nasdaq: ... premium diagnostic products, medical imaging systems and surgical products ... focus on two new, ready-to-market automated options for cervical ... Clinical Workshop (IPV) September 17th through 22nd in ...
Cached Medicine Technology:Medical Imaging of Fredericksburg Highlighted in Imaging Economics' Best of 2011 Radiology Facilities Issue 2Hologic Launches Automated Cervical Cancer Screening Solutions at IPV Meeting in Berlin 2Hologic Launches Automated Cervical Cancer Screening Solutions at IPV Meeting in Berlin 3Hologic Launches Automated Cervical Cancer Screening Solutions at IPV Meeting in Berlin 4
(Date:7/28/2015)... ... July 28, 2015 , ... One of the ... World Magazine, is plantar fasciitis . Zensah, the Miami-based compression brand, offers ... a professional athletic trainer, the Zensah Ankle Support’s primary benefits include helping support ...
(Date:7/28/2015)... ... 2015 , ... American Sentinel University has been named an ... Geisinger Health System (GHS), one of the nation’s largest integrated health services organizations. ... access to American Sentinel’s affordable, flexible and CCNE-accredited RN to BSN nursing degree ...
(Date:7/28/2015)... ... 28, 2015 , ... Carol McFarland, PT, PhD, OCS focuses ... of specific rehabilitation exercises and treatment protocols in the PTA OT PT ... extensive interview conducted by Carol with a board certified neurosurgeon. Specific case studies ...
(Date:7/28/2015)... ... July 28, 2015 , ... Want to improve your fitness level ... your easy chair? Luckily, there are plenty of back-friendly cardio exercises that are safe ... surgeon at Atlantic Spine Center . , It’s simply untrue that those ...
(Date:7/27/2015)... ... 2015 , ... Career Step, an online provider of career-focused education and corporate ... nationally endorsed on The Dave Ramsey Show. Dave’s endorsement can be heard on over ... , “It is a privilege to be highlighted on The Dave Ramsey Show,” said ...
Breaking Medicine News(10 mins):Health News:Zensah Releases Compression Sleeve To Relieve Ankle Pain and Plantar Fasciitis 2Health News:American Sentinel University Selected to Provide Online RN to BSN Cohorts to Geisinger Health System 2Health News:American Sentinel University Selected to Provide Online RN to BSN Cohorts to Geisinger Health System 3Health News:American Sentinel University Selected to Provide Online RN to BSN Cohorts to Geisinger Health System 4Health News:North American Seminars Introduces a New OT PT PTA Online Continuing Education Course on the Treatment of Post Surgical Cervical and Lumbar Spine Patients 2Health News:North American Seminars Introduces a New OT PT PTA Online Continuing Education Course on the Treatment of Post Surgical Cervical and Lumbar Spine Patients 3Health News:North American Seminars Introduces a New OT PT PTA Online Continuing Education Course on the Treatment of Post Surgical Cervical and Lumbar Spine Patients 4Health News:North American Seminars Introduces a New OT PT PTA Online Continuing Education Course on the Treatment of Post Surgical Cervical and Lumbar Spine Patients 5Health News:North American Seminars Introduces a New OT PT PTA Online Continuing Education Course on the Treatment of Post Surgical Cervical and Lumbar Spine Patients 6Health News:Safe Cardio for Back Pain Sufferers 2Health News:Safe Cardio for Back Pain Sufferers 3Health News:Career Step Nationally Endorsed on The Dave Ramsey Show 2Health News:Career Step Nationally Endorsed on The Dave Ramsey Show 3
... can learn much from each other in regard ... wrong-site surgeries, HARRISBURG, Pa., Jan. 10 ... decreased during 2007, some,facilities continue to report wrong-site ... protocols implemented by other Pennsylvania,facilities that have been ...
... Prepares to Release Alarming New HIV Rates; Governor ... 10 AIDS Healthcare,Foundation (AHF) today urged California ... of proposed budget cuts in AIDS services,that will ... for,Californians living with HIV/AIDS as he seeks to ...
... for "The Grove Circle," Honoring Planned Gift Donors,Reflects Shared ... - Andrew S. Grove,co-founder of technology giant Intel and ... Research, announced his intent to bequeath a,portion of his ... Fox Foundation.,Mr. Grove,s gift will establish The Grove Circle, ...
... can alter timetable , , THURSDAY, Jan. 10 (HealthDay News) -- ... a half years following their diagnosis, new British research shows. ... life expectancy, according to the report in the Jan. 11 ... Common socioeconomic influences, such as marital status, social class and ...
... January 9, 2008 In a study published ... from the University of Aberdeen report that the ... and praised as "the first and,only representative of ... fact similar,to other existing compounds, and is beneficial ...
... Animal study shows preconditioning cardiac cells helps organ better tolerate ... -- Just as daily runs can prepare you to survive ... spells could condition cardiac cells to better withstand the damage ... University of Cincinnati suggests. , Ultimately, if validated in humans, ...
Cached Medicine News:Health News:Patient Safety Authority Visits Facilities for Information on Wrong-Site Surgery 2Health News:Patient Safety Authority Visits Facilities for Information on Wrong-Site Surgery 3Health News:Patient Safety Authority Visits Facilities for Information on Wrong-Site Surgery 4Health News:AHF to Schwarzenegger: 'AIDS Cuts Are Deadly' 2Health News:AHF to Schwarzenegger: 'AIDS Cuts Are Deadly' 3Health News:Intel Co-Founder Andrew S. Grove Dedicates Portion of His Estate, Up to $40 Million, to Michael J. Fox Foundation 2Health News:Intel Co-Founder Andrew S. Grove Dedicates Portion of His Estate, Up to $40 Million, to Michael J. Fox Foundation 3Health News:Dementia Diagnosis Typically Means Death Within Five Years 2Health News:Memantine and Alzheimer's disease 2Health News:Memantine and Alzheimer's disease 3Health News:Priming Heart Before an Attack Could Limit Damage 2Health News:Priming Heart Before an Attack Could Limit Damage 3
... This comprehensive guide provides safe, ... administration information in a quickly ... 2006 edition includes the latest ... with key nursing implications are ...
Provides immediate access to comprehensive coverage of more than 325 I.V. drugs, blood products, and solutions....
... Nurse's Pocket Drug Guide 2005 includes over ... data relating to their selection and administration. ... each drug includes key data featuring common ... nursing implications and patient education information. A ...
... is a dynamic new mobile tool ... to check on the compatibility of ... drugs, clear compatibility and stability results ... take clinical action based on this ...
Medicine Products: